BigpAK-2: A biomarker-guided preventive care bundle cut moderate or severe acute kidney injury after major surgery (2025) — Trial Summary
BigpAK-2: A biomarker-guided preventive care bundle cut moderate or severe acute kidney injury after major surgery (2025): Multinational, multicenter randomized clinical trial at 34 hospitals in Europe. Adults (18 years or older) admitted to intensive care after major surgery who were at high risk f
References
- Zarbock A, Ostermann M, Forni L, et al; BigpAK-2 study group. A preventive care strategy to reduce moderate or severe acute kidney injury after major surgery (BigpAK-2): a multinational, randomised clinical trial. Lancet. 2025;406(10521):2782-2791.